
浏览全部资源
扫码关注微信
1.重庆医科大学基础医学院生物化学与分子生物学教研室,重庆 400016
2.重庆医科大学基础医学院组织学与胚胎学教研室,重庆 400016
张 涛,Email:taozyunlife@163.com,研究方向:分子肿瘤学。
张春冬,Email:zhangcd@cqmu.edu.cn。
收稿:2024-03-13,
修回:2024-05-24,
录用:2024-05-27,
纸质出版:2024-09-28
移动端阅览
张涛,张莲,张春冬.建立稳定敲减MINK1表达的肺腺癌细胞系及对其初步分析[J].重庆医科大学学报,2024,49(9):1072-1078.
Zhang Tao,Zhang Lian,Zhang Chundong.Establishment and preliminary analysis of lung adenocarcinoma cell lines with stable MINK1 knockdown[J].Journal of Chongqing Medical University,2024,49(9):1072-1078.
张涛,张莲,张春冬.建立稳定敲减MINK1表达的肺腺癌细胞系及对其初步分析[J].重庆医科大学学报,2024,49(9):1072-1078. DOI: 10.13406/j.cnki.cyxb.003589.
Zhang Tao,Zhang Lian,Zhang Chundong.Establishment and preliminary analysis of lung adenocarcinoma cell lines with stable MINK1 knockdown[J].Journal of Chongqing Medical University,2024,49(9):1072-1078. DOI: 10.13406/j.cnki.cyxb.003589.
目的
2
构建稳定敲减Misshapen/NIK-related kinase(MINK1)表达肺腺癌细胞系,并检测稳定敲减其表达后对细胞增殖、迁移运动及顺铂治疗的影响。
方法
2
利用肺腺癌A549和PC-9细胞,基于pLKO.1-shRNA慢病毒基因敲减表达系统构建稳定敲减MINK1表达细胞系,分别通过qRT-PCR和Western bolt在mRNA和蛋白水平检测敲减效率。CCK-8和Transwell检测稳定敲减MINK1表达对细胞增殖和迁移运动的影响,流式细胞检测细胞周期与凋亡变化情况;分析稳定敲减MINK1表达对顺铂治疗敏感性变化情况,并通过免疫荧光染色DNA损伤标志物γH2AX检测细胞DNA损伤水平。
结果
2
qRT-PCR和Western bolt分析结果显示2个特异shRNA均可显著下调MINK1表达。稳定敲减MINK1表达的肺腺癌细胞增殖能力降低,迁移运动能力下降;且敲减MINK1表达明显增强化疗药物顺铂对癌细胞杀伤作用,并诱导DNA损伤水平增加。
结论
2
利用肺腺癌A549和PC-9细胞成功构建稳定敲减MINK1肺腺癌细胞系,而稳定敲减其表达可抑制癌细胞增殖及迁移运动,且可能通过调节DNA损伤修复过程促肺癌细胞耐药。
Objective
2
To establish lung adenocarcinoma cell lines with stable knockdown of the expression of encoding Misshapen/NIK-related kinase(MINK1)and analyze the effects of stable MINK1 knockdown on cell proliferation,migration,and cisplatin treatment.
Methods
2
In lung adenocarcinoma A549 and PC-9 cells,cell lines with stable MINK1 knockdown were constructed based on the pLKO.1-shRNA lentiviral expression system. The knockdown efficiency was detected at the mRNA and protein levels using qRT-PCR and Western blot. CCK-8 and Transwell assays were used to assess the effects of stable MINK1 knockdown on cell proliferation and migration. Flow cytometry was used to detect changes in cell cycle and apoptosis. The sensitivity of cells with stable MINK1 knockdown to cisplatin treatment was analyzed. The level of DNA damage in cells was detected by immunofluorescence staining of the DNA damage marker γH2AX.
Results
2
qRT-PCR and Western blot showed that shRNA significantly downregulated the expression of MINK1. Proliferation and migration were reduced in lung adenocarcinoma cells with stable MINK1 knockdown. MINK1 knockdown significantly enhanced the cytotoxic effect of the chemotherapy drug cisplatin on cancer cells and induced an increase in the level of DNA damage.
Conclusion
2
Lung adenocarcinoma cell lines with stable MINK1 knockdown were successfully established using A549 and PC-9 cells. Stable MINK1 knockdown can inhibit cancer cell proliferation and migration and may reduce the drug resistance of lung cancer cells by regulating the DNA damage repair process.
Khwaja RM , Chu QS . Present and emerging biomarkers in immunotherapy for metastatic non-small cell lung cancer:a review [J ] . Curr Oncol , 2022 , 29 ( 2 ): 479 - 489 .
Calvayrac O , Pradines A , Pons E , et al . Molecular biomarkers for lung adenocarcinoma [J ] . Eur Respir J , 2017 , 49 ( 4 ): 1601734 .
Pu JY , Shen JF , Zhong ZH , et al . KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells [J ] . Artif Cells Nanomed Biotechnol , 2020 , 48 ( 1 ): 639 - 647 .
Verdecchia A , Francisci S , Brenner H , et al . Recent cancer survival in Europe:a 2000-02 period analysis of EUROCARE-4 data [J ] . Lancet Oncol , 2007 , 8 ( 9 ): 784 - 796 .
Yu SH , Zhang CL , Dong FS , et al . miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway [J ] . J Cell Biochem , 2015 , 116 ( 2 ): 268 - 276 .
Chalela R , Curull V , Enríquez C , et al . Lung adenocarcinoma:from molecular basis to genome-guided therapy and immunotherapy [J ] . J Thorac Dis , 2017 , 9 ( 7 ): 2142 - 2158 .
Vassel FM , Bian K , Walker GC , et al . Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer [J ] . Proc Natl Acad Sci U S A , 2020 , 117 ( 46 ): 28922 - 28924 .
Marine JC , Dawson SJ , Dawson MA . Non-genetic mechanisms of therapeutic resistance in cancer [J ] . Nat Rev Cancer , 2020 , 20 ( 12 ): 743 - 756 .
Galluzzi L , Senovilla L , Vitale I , et al . Molecular mechanisms of cisplatin resistance [J ] . Oncogene , 2012 , 31 ( 15 ): 1869 - 1883 .
Saleh AH , Samuel N , Juraschka K , et al . The biology of ependymomas andemerging novel therapies [J ] . Nat Rev Cancer , 2022 , 22 ( 4 ): 208 - 222 .
Hu YM , Leo C , Yu S , et al . Identification and functional characterization of a novel human misshapen/Nck interacting kinase-related kinase,hMINK beta [J ] . J Biol Chem , 2004 , 279 ( 52 ): 54387 - 54397 .
Nicke B , Bastien J , Khanna SJ , et al . Involvement of MINK,a Ste20 family kinase,in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells [J ] . Mol Cell , 2005 , 20 ( 5 ): 673 - 685 .
Larhammar M , Huntwork-Rodriguez S , Rudhard Y , et al . The Ste20 family kinases MAP4K4,MINK1,and TNIK converge to regulate stress-induced JNK signaling in neurons [J ] . J Neurosci , 2017 , 37 ( 46 ): 11074 - 11084 .
Daulat AM , Luu O , Sing A , et al . Mink1 regulates β-catenin-independent Wnt signaling via Prickle phosphorylation [J ] . Mol Cell Biol , 2012 , 32 ( 1 ): 173 - 185 .
Meng ZP , Moroishi T , Mottier-Pavie V , et al . MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway [J ] . Nat Commun , 2015 , 6 : 8357 .
Daulat AM , Bertucci F , Audebert S , et al . PRICKLE1 contributes to cancer cell dissemination through its interaction with mTORC2 [J ] . Dev Cell , 2016 , 37 ( 4 ): 311 - 325 .
Zhang L , Zhang Y , Lei YL , et al . Proline-rich 11(PRR11)drives F-actin assembly by recruiting the actin-related protein 2/3 complex in human non-small cell lung carcinoma [J ] . J Biol Chem , 2020 , 295 ( 16 ): 5335 - 5349 .
Zhou J , Liu H , Zhang L , et al . DJ-1 promotes colorectal cancer progression through activating PLAGL2/Wnt/BMP4 axis [J ] . Cell Death Dis , 2018 , 9 ( 9 ): 865 .
Devarakonda S , Morgensztern D , Govindan R . Genomic alterations in lung adenocarcinoma [J ] . Lancet Oncol , 2015 , 16 ( 7 ): e342 - e351 .
Meric-Bernstam F , Mills GB . Overcoming implementation challenges of personalized cancer therapy [J ] . Nat Rev Clin Oncol , 2012 , 9 ( 9 ): 542 - 548 .
Dan I , Watanabe NM , Kusumi A . The Ste20 group kinases as regulators of MAP kinase cascades [J ] . Trends Cell Biol , 2001 , 11 ( 5 ): 220 - 230 .
Miller CJ , Lou HJ , Simpson C , et al . Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output [J ] . PLoS Biol , 2019 , 17 ( 3 ): e2006540 .
Meng ZP , Qiu YJ , Lin KC , et al . RAP2 mediates mechanoresponses of the Hippo pathway [J ] . Nature , 2018 , 560 ( 7720 ): 655 - 660 .
Deng M , Lin J , Nowsheen S , et al . Extracellular matrix stiffness determines DNA repair efficiency and cellular sensitivity to genotoxic agents [J ] . Sci Adv , 2020 , 6 ( 37 ): eabb2630 .
代娟丽 , 王 臻 , 董超雄 , 等 . RVM致炎细胞因子上调导致5-HT释放参与调控慢性术后疼痛 [J ] . 中山大学学报(医学科学版) , 2024 , 45 ( 1 ): 54 - 62 .
Dai JL , Wang Z , Dong CX , et al . Up-regulation of proinflammatory cytokines in rostral ventromedial medulla contributes to chronic postsurgical pain by promoting 5-HT release [J ] . J Sun Yat Sen Univ Med Sci , 2024 , 45 ( 1 ): 54 - 62 .
Fu GT , Xu Q , Qiu YJ , et al . Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1 [J ] . J Exp Med , 2017 , 214 ( 5 ): 1453 - 1469 .
Yue JP , Xie M , Gou XW , et al . Microtubules regulate focal adhesion dynamics through MAP4K4 [J ] . Dev Cell , 2014 , 31 ( 5 ): 572 - 585 .
Torres-Ayuso P , An E , Nyswaner KM , et al . TNIK is a therapeutic target in lung squamous cell carcinoma and regulates FAK activation through merlin [J ] . Cancer Discov , 2021 , 11 ( 6 ): 1411 - 1423 .
王 茹 , 尹 讯 , 张涛 , 等 . 建立稳定敲减MAP4K4表达的A549细胞系及初步分析 [J ] . 四川大学学报(医学版) , 2022 , 53 ( 4 ): 611 - 618 .
Wang R , Yin X , Zhang T , et al . Establishment and preliminary analysis of lung cancer cell line A549 with stable MAP4K4 knockdown [J ] . J Sichuan Univ Med Sci , 2022 , 53 ( 4 ): 611 - 618 .
孙雪花 , 尹 讯 , 王茹 , 等 . 建立稳定敲减TNIK表达的A549细胞系及对其初步分析 [J ] . 中国细胞生物学学报 , 2022 , 44 ( 3 ): 421 - 428 .
Sun XH , Yin X , Wang R , et al . Establishment and preliminary analysis of cell line A549 with stable knockdown of TNIK expression [J ] . Chin J Cell Biol , 2022 , 44 ( 3 ): 421 - 428 .
0
浏览量
13
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621